$8.8
Live
Revenue is up for the last 6 quarters, 26.51M → 30.37M (in $), with an average increase of 2.7% per quarter
Netprofit is down for the last 3 quarters, 443.0K → -324.0K (in $), with an average decrease of 239.3% per quarter
In the last 1 year, Intuitive Surgical Inc has given 33.9% return, outperforming this stock by 41.3%
In the last 3 years, West Pharmaceutical Services, Inc. has given 58.7% return, outperforming this stock by 82.0%
0.0%
Downside
Day's Volatility :4.03%
Upside
4.03%
30.68%
Downside
52 Weeks Volatility :43.93%
Upside
19.12%
Period | INFUSYSTEM HOLDINGS INC | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -5.22% | 0.3% | -6.7% |
6 Months | 3.73% | -8.3% | -6.2% |
1 Year | -7.96% | -4.8% | -6.3% |
3 Years | -23.93% | 23.8% | 26.9% |
Market Capitalization | 186.3M |
Book Value | $2.31 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | 0.0 |
PE Ratio | 0.0 |
PEG Ratio | 0.0 |
Wall Street Target Price | 15.17 |
Profit Margin | 0.06% |
Operating Margin TTM | 1.83% |
Return On Assets TTM | 1.29% |
Return On Equity TTM | 0.13% |
Revenue TTM | 113.4M |
Revenue Per Share TTM | 5.47 |
Quarterly Revenue Growth YOY | 13.3% |
Gross Profit TTM | 62.5M |
EBITDA | 15.1M |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | -0.5 |
EPS Estimate Current Year | 0.06 |
EPS Estimate Next Year | 0.22 |
EPS Estimate Current Quarter | 0.02 |
EPS Estimate Next Quarter | 0.03 |
What analysts predicted
Upside of 72.39%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 71.1M | ↑ 0.82% |
Net Income | -20.7M | ↑ 9227.48% |
Net Profit Margin | -29.13% | ↓ 28.82% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 67.1M | ↓ 5.54% |
Net Income | -1.1M | ↓ 94.71% |
Net Profit Margin | -1.63% | ↑ 27.5% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 81.1M | ↑ 20.82% |
Net Income | 1.4M | ↓ 224.29% |
Net Profit Margin | 1.68% | ↑ 3.31% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 97.4M | ↑ 20.06% |
Net Income | 17.3M | ↑ 1173.48% |
Net Profit Margin | 17.8% | ↑ 16.12% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 102.4M | ↑ 5.13% |
Net Income | 1.4M | ↓ 91.81% |
Net Profit Margin | 1.39% | ↓ 16.41% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 109.9M | ↑ 7.36% |
Net Income | 18.0K | ↓ 98.73% |
Net Profit Margin | 0.02% | ↓ 1.37% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 26.5M | ↓ 0.18% |
Net Income | 387.0K | ↓ 186.38% |
Net Profit Margin | 1.46% | ↑ 3.15% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 26.8M | ↑ 0.92% |
Net Income | -368.0K | ↓ 195.09% |
Net Profit Margin | -1.38% | ↓ 2.84% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 27.0M | ↑ 1.04% |
Net Income | -164.0K | ↓ 55.43% |
Net Profit Margin | -0.61% | ↑ 0.77% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 27.3M | ↑ 0.88% |
Net Income | 443.0K | ↓ 370.12% |
Net Profit Margin | 1.62% | ↑ 2.23% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 28.8M | ↑ 5.69% |
Net Income | 107.0K | ↓ 75.85% |
Net Profit Margin | 0.37% | ↓ 1.25% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 30.4M | ↑ 5.34% |
Net Income | -324.0K | ↓ 402.8% |
Net Profit Margin | -1.07% | ↓ 1.44% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 68.9M | ↓ 28.51% |
Total Liabilities | 37.9M | ↓ 16.92% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 64.1M | ↓ 6.98% |
Total Liabilities | 43.6M | ↑ 15.04% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 79.2M | ↑ 23.65% |
Total Liabilities | 56.9M | ↑ 30.39% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 45.2M | ↓ 42.89% |
Total Liabilities | 56.2M | ↓ 1.14% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 97.6M | ↑ 115.69% |
Total Liabilities | 49.3M | ↓ 12.31% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 99.4M | ↑ 1.85% |
Total Liabilities | 51.4M | ↑ 4.2% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 97.6M | ↑ 2.95% |
Total Liabilities | 49.3M | ↑ 2.03% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 98.2M | ↑ 0.67% |
Total Liabilities | 52.2M | ↑ 5.82% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 98.8M | ↑ 0.59% |
Total Liabilities | 52.3M | ↑ 0.26% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 99.0M | ↑ 0.17% |
Total Liabilities | 51.2M | ↓ 2.19% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 99.4M | ↑ 0.41% |
Total Liabilities | 51.4M | ↑ 0.41% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 102.3M | ↑ 2.89% |
Total Liabilities | 54.0M | ↑ 5.09% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.6M | ↓ 4.12% |
Investing Cash Flow | 1.1M | ↓ 119.7% |
Financing Cash Flow | -8.6M | ↓ 57200.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 11.4M | ↑ 50.22% |
Investing Cash Flow | -5.0M | ↓ 573.31% |
Financing Cash Flow | -5.6M | ↓ 35.11% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 13.9M | ↑ 21.81% |
Investing Cash Flow | -19.6M | ↑ 294.12% |
Financing Cash Flow | 4.1M | ↓ 173.71% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 20.3M | ↑ 46.16% |
Investing Cash Flow | -12.2M | ↓ 38.08% |
Financing Cash Flow | -1.1M | ↓ 127.26% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.3M | ↓ 9.68% |
Investing Cash Flow | -21.3M | ↑ 75.26% |
Financing Cash Flow | -6.5M | ↑ 478.6% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.7M | ↓ 35.92% |
Investing Cash Flow | -5.6M | ↑ 27.19% |
Financing Cash Flow | 1.9M | ↓ 241.8% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 9.89% |
Investing Cash Flow | -2.1M | ↓ 61.92% |
Financing Cash Flow | -1.7M | ↓ 188.59% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.4M | ↑ 32.83% |
Investing Cash Flow | -2.8M | ↑ 29.77% |
Financing Cash Flow | -2.7M | ↑ 59.09% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 3.5M | ↓ 36.2% |
Investing Cash Flow | -3.5M | ↑ 25.93% |
Financing Cash Flow | 98.0K | ↓ 103.59% |
Sell
Neutral
Buy
INFUSYSTEM HOLDINGS INC is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() INFUSYSTEM HOLDINGS INC | 0.79% | 3.73% | -7.96% | -23.93% | 182.54% |
![]() Intuitive Surgical, Inc. | 1.28% | 13.5% | 34.82% | 60.24% | 100.3% |
![]() ResMed Inc. | -8.1% | -6.41% | 5.89% | 33.71% | 110.04% |
![]() Becton, Dickinson and Company | -9.12% | -3.3% | -5.74% | -1.52% | 7.87% |
![]() West Pharmaceutical Services Inc | -6.18% | 46.38% | 10.67% | 61.92% | 264.96% |
![]() Alcon AG | 9.79% | 14.75% | 5.78% | 24.18% | 36.2% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() INFUSYSTEM HOLDINGS INC | 0.0 | 0.0 | 0.0 | 0.06 | 0.0 | 0.01 | 0.0 | 2.31 |
![]() Intuitive Surgical, Inc. | 83.4 | 83.4 | 3.27 | 5.47 | 0.11 | 0.07 | 0.0 | 32.01 |
![]() ResMed Inc. | 36.76 | 36.76 | 1.74 | 6.52 | 0.24 | 0.12 | 0.01 | 26.77 |
![]() Becton, Dickinson and Company | 44.32 | 44.32 | 2.31 | 12.2 | 0.07 | 0.03 | 0.02 | 90.44 |
![]() West Pharmaceutical Services Inc | 47.18 | 47.18 | 4.06 | 7.69 | 0.22 | 0.13 | 0.0 | 37.42 |
![]() Alcon AG | 114.57 | 114.57 | NA | 2.64 | 0.02 | 0.02 | 0.0 | 40.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() INFUSYSTEM HOLDINGS INC | Buy | $186.3M | 182.54% | 0.0 | 0.06% |
![]() Intuitive Surgical, Inc. | Buy | $107.5B | 100.3% | 83.4 | 20.4% |
![]() ResMed Inc. | Buy | $31.7B | 110.04% | 36.76 | 21.49% |
![]() Becton, Dickinson and Company | Buy | $68.5B | 7.87% | 44.32 | 8.6% |
![]() West Pharmaceutical Services Inc | Buy | $25.5B | 264.96% | 47.18 | 19.15% |
![]() Alcon AG | Buy | $38.9B | 36.2% | 114.57 | 3.84% |
InfuSystem Holdings, Inc., is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services ('ITS'), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, and Wound Therapy businesses. The second platform, Durable Medical Equipment Services ('DME Services'), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payor clients. The DME Services segment is comprised of direct payor rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada.
Organization | INFUSYSTEM HOLDINGS INC |
Employees | 420 |
CEO | Mr. Richard A. DiIorio |
Industry | Health Technology |
First Majestic Silver Corp
$5.66
-1.57%
ONYX ACQUISITION CO. I
$10.50
-4.55%
Diversified Healthcare Trust
$1.25
+9.65%
ALTC ACQUISITION CORP-CL A
$10.68
+0.28%
iShares Morningstar Value ETF
$63.26
-0.24%
Nationwide Nasdaq-100 Risk-Managed Income ETF
$20.50
+0.1%
ENFUSION INC
$7.81
-0.89%
WisdomTree Trust - WisdomTree International Quality Dividend Growth Fund
$33.45
-1.21%
GIGACLOUD TECHNOLOGY INC
$6.76
+4.81%